Trinity Biotech Plc (TRIB) Institutional Ownership

Ownership Summary

Recent 13F filings as of December 2025 show that 10 institutional investors hold a position in Trinity Biotech Plc (NASDAQ:TRIB).

• The collective stake of institutional investors in Trinity Biotech moved to 2.9% in December 2025, a shift down from the 11.1% reported for September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 24.41%, with a year-over-year a decrease of 56.52% in the count of filers.
• A review of institutional activity for Trinity Biotech shows 4 of 10 filers increasing their positions, while 1 reduced their stake, and 5 remained unchanged.
• The total number of shares held by institutions in Trinity Biotech increased to 695.66K as of December 2025, a net change of up by 136.50K shares quarter on quarter, and down 1.92Mn shares year over year.
• HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC's holding of 526.61K shares as of December 31, 2025 makes it the primary institutional investor in Trinity Biotech, owning 2.17% of the stock.
• Among the most significant buyers of Trinity Biotech during December 2025 were Williams & Novak, LLC (81.30K), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (39.50K), INSPIRION WEALTH ADVISORS, LLC (15.00K), UBS Group AG (729).
• Leading sellers of Trinity Biotech stock in December 2025 included NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (24).
• The top 10 institutional holders of Trinity Biotech for the quarter ending December 2025 included HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (526.61K), Williams & Novak, LLC (93.30K), Moss Adams Wealth Advisors LLC (25.67K), INSPIRION WEALTH ADVISORS, LLC (25.00K), Cambridge Investment Research Advisors, Inc. (22.28K), Farther Finance Advisors, LLC (2.00K), UBS Group AG (780), ATWOOD & PALMER INC (20), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (1), CoreCap Advisors, LLC (1).